Browse All

Current Filters

CLEAR FILTER x

TITLE

Responder Rates With Eptinezumab Over 24 Weeks in Patients With Prior Migraine Preventive Treatment Failures

Author:Ashina, Messoud   Lipton, Richard B   Ailani, Jessica   Versijpt, Jan   Sacco, Simona   Mitsikostas, Dimos D   Christoffersen, Cecilie   Sperling, Bjorn   Ettrup, Anders   

Session Name:S47: Advances in Migraine Therapeutics  

Topic:Headache  

Program Number:S47.007  

Author Institution:Danish Headache Center, Rigshospitalet Glostrup, University of Copenhagen, Copenhagen, Denmark  Department of Neurology, Albert Einstein College of Medicine, Bronx, NY  Department of Neurology, Georgetown University Hospital, Washington DC, WA  Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Department of Neurology, Brussels, Belgium  Department of Biotechnological and Clinical Sciences, University of L’Aquila, L'Aquila, Italy  1st Department of Neurology, Aeginition Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece  H. Lundbeck A/S, Copenhagen, Denmark